from    
to    
search  

 


学堂班系列讲座:“人工光合作用”
【千帆讲堂】对话NEJM主编Eric Rubin:Safe but not too safe – human challenge i...
中国新型城镇化理论·政策·实践论坛2023
航空发动机三维数值仿真软件研发进展
报告题目:
Development and Production of Human Biotherapeutics
 报告人:
James Leung
Visiting Scientist 

Biology department & Center for Biomedical Innovations,MIT
报告时间:
2010-03-02 10:30
报告地点:
化学工程系(工物馆 324-东 会议室)
主办单位:
化学工程系
  简介:

Dr. Leung is a Visiting Scientist at MIT participating in biotechnology research projects in the Biology and Chemical Engineering departments. He also engages with biotechnology and pharmaceutical companies by serving as consulting advisor in the areas of biotherapeutic development and manufacturing.

 

For the last ten years, Dr. Leung was the Vice President of Biotechnology at Ipsen, an international pharmaceutical company headquartered in France and the United Kingdom. Prior to Ipsen, from 1995 to 1998, he worked as an independent consultant advising startup biotechnology companies in the United States and Asia, and served as industrial coordinator for two consortia at MIT – BioProcess Engineering Center (BPEC) and Consortium for the Advanced Manufacturing of Pharmaceuticals (CAMP). From 1993 to 1995, Dr. Leung was the Senior Vice President of Operations at Repligen Corp., a public biotechnology company focused on developing novel therapeutics for neurological disorders. Dr. Leung started his biotechnology career at Genentech, Inc.

 

Dr. Leung received a B.Sc. degree from the Chemical Engineering Department at MIT, and a M.Sc. degree and a Ph.D. degree in biochemical engineering from MIT.

今日相关信息
中国发展道路研讨会暨《中国向何处去》和《...
 
同类别相关信息
CNEX-AOC【机不可失】纪录片全国校园巡...
Perspective of cellulose nanomaterials
Fiber Diffraction Study of Cellulos...
清华大学科学社会学与政策学沙龙第91期...
动物伦理学与护生文化系列讲座第24讲:...
学术活动